RGWEX | VLIIX | RGWEX / VLIIX | |
Total Expense Ratio | 0.71 | 0.83 | 86% |
Annual Report Gross Expense Ratio | 0.71 | 0.88 | 81% |
Fund Existence | 13 years | 10 years | - |
Gain YTD | 16.719 | 17.498 | 96% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 100000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 24.2B | 519M | 4,663% |
Annual Yield % from dividends | 0.41 | 0.90 | 45% |
Returns for 1 year | 16.10 | 28.41 | 57% |
Returns for 3 years | 50.32 | 61.59 | 82% |
Returns for 5 years | 47.21 | 32.27 | 146% |
Returns for 10 years | 100.69 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
SYNB | 30.28 | 0.38 | +1.27% |
Putnam BioRevolution ETF | |||
BJAN | 52.55 | N/A | +0.01% |
Innovator US Equity Buff ETF™ Jan | |||
LDRI | 25.72 | -0.03 | -0.10% |
iShares iBonds 1-5 Year TIPS Ladder ETF | |||
CORP | 98.89 | -0.14 | -0.14% |
PIMCO Investment Grade Corporate Bd ETF | |||
VEGA | 48.21 | -0.10 | -0.21% |
AdvisorShares STAR Global Buy-Write ETF |